Role of Pharmaceutical Automation and Robotics in Pharmaceutical Industry: A Review

Abstract

Sandip Suresh Khandagale69345*, Nalawade Omkar Bappasaheb69340, Aarti Suresh Khose69341, Priyanka Kshirsagar69342, Pratiksha Nemane69343 and Rohini Haribhau Thube69344

This analysis focuses on how robotics and Artificial Intelligence (AI) is becoming more and more important in the pharmaceutical industry. It might be especially helpful for India, a country with a big and expanding population and little access to healthcare resources in its rural areas. AI uses quick and sophisticated algorithms to combine vast volumes of data. This enables the software to swiftly adjust the data characteristics’ pattern. It could potentially clash with the majority of the health system’s components, from detection to prevention and deterrent. Over the past few years, there has been a noticeable increase in the application of AI and robots in the healthcare industry. Activities such as drug development, clinical trials, and quality assurance are some of the tasks that may be managed with great efficiency using artificial intelligence in urban and rural areas across the country. Artificial Intelligence (AI) in the pharmaceutical industry offers benefits such as privileged patient treatment during clinical trials, safe working environments with reduced human infection risk, and efficiently managed operational duties. The healthcare industry, which is among the largest and most dynamic in the world, has a tendency to advance development through innovation and modernization. This profitable business is anticipating a major breakthrough in the future that will generate intelligent machines that think and act like people. Future applications of AI and robots in healthcare include, drug development, identification of fatal illnesses, remote prescription monitoring, remote prescription monitoring and geriatric care, etc. However, given the cost, the shortage of skilled labor, and people’s ingrained mindset, the viability of deploying robotics in the pharmaceutical industry may be called into doubt. The largest obstacle is transferring this technology to industrial areas so that these facilities may serve a greater portion of the nation’s population. The purpose of this review is to identify the main obstacles and assess how viable and adaptable these new technologies are in the Indian context.